Citigroup’s IM Cannabis IMCC Stock Holding History

Citigroup’s Portfolio IMCC Stock Details IMCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11	Closed	-$1K	–	6420
2022 Q1	$1K	Buy	+11	New	+$1.5K	﹤0.01%	6176

Other funds holding IMCC

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

KJHP

K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ECM

EMC Capital Management Houston, Texas $225M AUM 25.8% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citigroup's IMCC Position: Q2 2022 in Review

Citigroup sold out of IM Cannabis (IMCC) in Q2 2022, closing a stake of 11 shares — an estimated $1K sold.

Citigroup first reported a position in IMCC in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 30 funds tracked by Wall St. Rank hold IMCC as of Q2 2022.

Citigroup reported no remaining IM Cannabis position as of Q2 2022 after selling out during the quarter.
Citigroup sold 11 IM Cannabis shares in Q2 2022, an estimated $1K.
Citigroup first reported a position in IM Cannabis in Q1 2022 and held it in 1 quarter.
Citigroup's IM Cannabis position peaked at $1K in Q1 2022.
30 funds tracked by Wall St. Rank held IM Cannabis as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.